288. Autoimmune acquired coagulation factor deficiency Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 35 / Drugs : 45 - (DrugBank : 11) / Drug target genes : 8 - Drug target pathways : 19
| Other names | Coagulation factor deficiency; | ||
|---|---|---|---|
| Disease group | Hematologic diseases | ||
|
Domestic patients
Med expenses recipients, FY2024 (corrected) (in Japanese) |
496 patients Age distribution
|
||
| Clinical research form (in Japanese) MHLW Intractable Diseases, FY2026 (in Japanese) | Overview, diagnostic criteria, etc. (pdf), Clinical research form (pdf) | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | - | ||
| Sub-diseases (Clinical research forms may not be available for all sub-diseases.) | No. | Name | Specific pediatric chronic diseases, Japan (in Japanese) |
| 288-1. | Acquired factor XIII deficiency;Autoimmune acquired factor XIII (F13) deficiency; | ||
| 288-2. | Acquired factor VIII deficiency;Autoimmune acquired factor VIII (F8) deficiency;Acquired hemophilia A; | ||
| 288-3. | VWF deficiency;Acquired von Willebrand syndrome;Acquired von Willebrand Disease;AVWS;AVWD; | ||
| 288-4. | Acquired factor V deficiency;Autoimmune acquired factor V (F5) deficiency; | ||
| 288-5. | Acquired factor X deficiency; | ||
